Litcius/Paper detail

Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications

Jeffrey Teoh, Lauren F. Brown

2022Cytotherapy24 citationsDOI

Topics & Concepts

Chimeric antigen receptorLeukapheresisCD8T cellCytotoxic T cellImmunologyMedicineAntigenCancer researchBiologyImmune systemCD34Stem cellCell biologyBiochemistryIn vitroCAR-T cell therapy researchBiosimilars and Bioanalytical MethodsViral Infectious Diseases and Gene Expression in Insects
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications | Litcius